These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Author: Ishibashi T, Mitomi A, Tatebe S, Imai S.
    Journal: Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836.
    Abstract:
    Cardiohemodynamic effects and the beta-blocking action of a new beta-adrenoceptor blocking agent, bopindolol (Sandonorm) were compared with those of pindolol in conscious unrestrained dogs. The intravenous injection of pindolol (3-100 micrograms/kg) increased the heart rate and decreased the total peripheral resistance dose-dependently and markedly, while the same doses of bopindolol had no effect on the heart rate and decreased the total peripheral resistance only at the maximum dose (100 micrograms/kg). These changes were antagonized by propranolol (3 mg/kg). Isoprenaline (isoproterenol, 0.1 microgram/kg)-induced tachycardia was inhibited dose-dependently by both beta-blockers to similar degrees. While the decrease in the total peripheral resistance by isoprenaline was inhibited by pindolol dose-dependently, the inhibition by lower doses of bopindolol was not so marked; the inhibition became greater as the doses of bopindolol were increased. These results indicate that bopindolol is a beta 1-selective beta-blocker with an affinity to this subtype of the beta-adrenoceptor comparable to that of pindolol. Unlike pindolol, it exerted no partial agonist activity at the beta-adrenoceptor. Instead it produced the partial agonist activity at the beta 2-adrenoceptor at the highest dose tested.
    [Abstract] [Full Text] [Related] [New Search]